|
May 3
|
Dow Jones Jumps 400 Points As Apple Stock Surges; Nvidia Jumps Again, Tempts New Buyers
|
|
May 3
|
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
|
|
May 3
|
US STOCKS-Wall St rallies after soft jobs data allays rate jitters
|
|
May 3
|
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
|
|
May 3
|
Weight-loss drug competition heats up. Is Wegovy in trouble?
|
|
May 3
|
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
|
|
May 3
|
Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug.
|
|
May 3
|
US STOCKS-Wall St gains after soft jobs data allays rate jitters
|
|
May 3
|
Amgen surges over confidence in early obesity drug results
|
|
May 3
|
These Two Stocks Are Driving the Dow Friday
|
|
May 3
|
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
|
|
May 3
|
US STOCKS-Wall St set to open sharply higher on soft jobs data
|
|
May 2
|
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
|
|
May 2
|
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
|
|
May 2
|
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
|
|
May 2
|
Amgen, DraftKings, Live Nation: Trending tickers
|
|
May 2
|
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
|
|
May 2
|
Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up
|
|
May 2
|
Amgen 'encouraged' by weight-loss drug interim data, shares jump
|